F. G. Barr, E. A. Montgomery, A. F. Nascimento, and D. M. Parham, WHO classification of tumours of soft tissue and bone, pp.124-135, 2013.

J. M. Mosquera, A. Sboner, L. Zhang, N. Kitabayashi, C. L. Chen et al., Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma, Genes Chromosomes Cancer, vol.52, pp.538-50, 2013.

R. Alaggio, L. Zhang, Y. S. Sung, S. C. Huang, C. L. Chen et al., A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases, Am J Surg Pathol, vol.40, pp.224-259, 2016.

S. Kohsaka, N. Shukla, N. Ameur, T. Ito, C. K. Ng et al., A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations, Nat Genet, vol.46, pp.595-600, 2014.

K. Szuhai, D. De-jong, W. Y. Leung, C. D. Fletcher, and P. C. Hogendoorn, Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma, J Pathol, vol.232, pp.300-307, 2014.

S. Watson, V. Perrin, D. Guillemot, S. Reynaud, J. M. Coindre et al., Transcriptomic definition of molecular subgroups of small round cell sarcomas, J Pathol, vol.245, pp.29-40, 2018.

N. K. Dashti, R. N. Wehrs, B. C. Thomas, A. Nair, J. Davila et al., Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype, Histopathology, vol.73, pp.514-534, 2018.

N. P. Agaram, L. Zhang, Y. S. Sung, M. S. Cavalcanti, D. Torrence et al., Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype, Am J Surg Pathol, vol.43, pp.695-702, 2019.

Y. Tagami, S. Sugita, T. Kubo, N. Iesato, M. Emori et al., Spindle cell rhabdomyosarcoma in a lumbar vertebra with FUS-TFCP2 fusion, Pathol Res Pract, 2019.

G. Zhu, R. Benayed, C. Ho, K. Mullaney, P. Sukhadia et al., Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma, Mod Pathol, vol.32, pp.609-620, 2018.

N. L. Bray, H. Pimentel, P. Melsted, and L. Pachter, Near-optimal probabilistic RNA-seq quantification, Nat Biotechnol, vol.34, pp.525-532, 2016.

M. D. Wilkerson and D. N. Hayes, ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking, Bioinformatics, vol.26, pp.1572-1575, 2010.

S. W. Lam, A. M. Cleton-jansen, A. Cleven, D. Ruano, T. Van-wezel et al.,

, Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing, J Mol Diagn, vol.20, pp.653-63, 2018.

T. Wiesner, W. Lee, A. C. Obenauf, L. Ran, R. Murali et al., Alternative transcription initiation leads to expression of a novel ALK isoform in cancer, Nature, vol.526, pp.453-460, 2015.

N. P. Agaram, Update on Myogenic Sarcomas, Surg Pathol Clin, vol.12, pp.51-62, 2019.

W. G. Mccluggage, A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus, Mod Pathol, vol.29, issue.1, pp.78-91, 2016.

L. Loarer, F. Laffont, S. Lesluyes, T. Tirode, F. Antonescu et al., Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum, Am J Surg Pathol, 2019.

A. L. Folpe, R. P. Graham, A. Martinez, D. Schembri-wismayer, J. Boland et al.,

, Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: a potential diagnostic pitfall, Hum Pathol, vol.77, pp.28-34, 2018.

N. Galili, R. J. Davis, W. J. Fredericks, S. Mukhopadhyay, F. J. Rauscher et al., Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma, Nat Genet, vol.5, pp.230-235, 1993.

D. D. Wong, C. Van-vliet, A. Gaman, T. Giardina, and B. Amanuel, Rhabdomyosarcoma with FUS rearrangement: additional case in support of a novel subtype, Pathology, vol.51, pp.116-136, 2019.

I. Iatrou, N. Theologie-lygidakis, O. Schoinohoriti, F. Tzermpos, and A. M. Vessala,

, Rhabdomyosarcoma of the maxillofacial region in children and adolescents: Report of 9 cases and literature review, J Craniomaxillofac Surg, vol.45, pp.831-838, 2017.

D. R. Lucas, J. R. Ryan, M. M. Zalupski, M. L. Gross, Y. Ravindranath et al., Primary embryonal rhabdomyosarcoma of long bone. Case report and review of the literature, Am J Surg Pathol, vol.20, pp.239-283, 1996.

V. Y. Jo, A. Mariño-enríquez, and C. D. Fletcher, Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma, Am J Surg Pathol, vol.35, pp.1523-1553, 2011.

J. Veljkovic and U. Hansen, Lineage-specific and ubiquitous biological roles of the mammalian transcription factor LSF, Gene, vol.343, pp.23-40, 2004.

S. L. Swendeman, C. Spielholz, N. A. Jenkins, D. J. Gilbert, N. G. Copeland et al., Characterization of the genomic structure, chromosomal location, promoter, and development expression of the alpha-globin transcription factor CP2, J Biol Chem, vol.269, pp.11663-71, 1994.

G. Kotarba, E. Krzywinska, A. I. Grabowska, A. Taracha, and T. Wilanowski, TFCP2/TFCP2L1/UBP1 transcription factors in cancer, Cancer Lett, vol.28, pp.72-79, 2018.

B. K. Yoo, L. Emdad, R. Gredler, C. Fuller, D. Cl et al., Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma, Proc Natl Acad Sci U S A, vol.107, pp.8357-62, 2010.

B. K. Yoo, R. Gredler, D. Chen, P. K. Santhekadur, P. B. Fisher et al., c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF, J Hepatol, vol.55, pp.1317-1341, 2011.

Y. Luo, J. Blechingberg, A. M. Fernandes, S. Li, T. Fryland et al., EWS and FUS bind a subset of transcribed genes encoding proteins enriched in RNA regulatory functions, BMC Genomics, vol.16, p.929, 2015.

A. Yoshida, T. Shibata, S. Wakai, T. Ushiku, K. Tsuta et al., Anaplastic lymphoma kinase status in rhabdomyosarcomas, Mod Pathol, vol.26, pp.772-81, 2013.

K. Pillay, D. Govender, and R. Chetty, ALK protein expression in rhabdomyosarcomas, Histopathology, vol.41, pp.461-468, 2002.

M. Wierdl, L. Tsurkan, C. L. Hatfield, M. J. Tollemar, V. Bradley et al., Targeting ALK in pediatric RMS does not induce antitumor activity in vivo, Cancer chemother Pharmacol, vol.82, pp.251-63, 2018.

P. Schoffski, A. Wozniak, M. G. Leahy, S. Aamdal, P. Rutkowski et al., The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 'CREATE', Eur J Cancer, vol.94, pp.156-67, 2018.

A. Chougule, M. S. Taylor, V. Nardi, I. Chebib, G. M. Cote et al., Spindle and Round Cell Sarcoma With EWSR1-PATZ1 Gene Fusion: A Sarcoma With Polyphenotypic Differentiation

, Am J Surg Pathol, vol.43, pp.220-228, 2019.